https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
nge of procedures. Chronic kidney disease (CKD) is a global non-communicable health problem. Fibrosis is considered the base and the fate of CKD; thus, the goal of this study was to evaluate the effects of sodium molybdate on cisplatin-induced CKD model and demonstrate the possible involved mechanisms. In cisplatin model, Wistar rats were challenged with cisplatin (1mg/kg, i.p.) twice weekly for ten weeks. Sodium molybdate (100 and 200mg/kg, orally) was given one-week prior cisplatin and was continued daily for the next ten
Like
Comment
Share
